We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Novartis Gains Rights to Two Oral Targeted Investigational Therapies

News   Dec 01, 2009

 
Novartis Gains Rights to Two Oral Targeted Investigational Therapies
 
 
 

RELATED ARTICLES

Roots of Neuropsychiatric Risk in the Developing Brain

News

The most comprehensive genomic analysis of the human brain ever undertaken has revealed new insights into the changes it undergoes through development, how it varies among individuals, and the roots of neuropsychiatric illnesses such as autism spectrum disorders and schizophrenia.

READ MORE

Drug Seeks Out Receptors in Sarcoma Cells, Shrinks Tumors

News

A new compound that targets a receptor within sarcoma cancer cells shrank tumors and hampered their ability to spread in mice and pigs, a study from researchers at the University of Illinois reports.

READ MORE

Blood Test May Enable Tailored Cystic Fibrosis Treatment

News

Study used blood test to identify distinct molecular signatures of disease; paves the way to precision medicine for cystic fibrosis.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE